Pre-Activity Survey Question Title * 1. Which of the following best describes your profession? ID Physician Infection Control Physician Microbiologist Pharmacist Research Scientist Other (please specify) Question Title * 2. My practice setting is... Teaching Hospital Specialty Hospital VA Setting Government Agency Academia Industry Other (please specify) Question Title * 3. During the past 12 months, what changes have you observed at your institution regarding the prevention and management of HAIs? Increased focus on antimicrobial stewardship efforts Formulary changes/restriction of antimicrobials Institutional guidelines on antimicrobial selection and dosing Increased efforts in infection control Use of bundled approaches of care Greater emphasis on de-escalation of therapy Other (please specify) Question Title * 4. Which of the following would you consider to be risk factors for a MDR infection? (check all that apply) High frequency of resistance in a hospital unit Current hospitalization for 5 or more days Recent prior hospitalization No prior antibiotic use Previous antimicrobial use (within past 3 months) Residence in a nursing home Diabetes Other (please specify) Question Title * 5. What barriers to the optimal management of HAIs continue to be in place at your institution? Lack of qualified personnel/resources Non-adherence to evidence-based guidelines Non-compliance to infection control measures Lack of educational resources/opportunities Resistance to change traditional practices Other (please specify) Question Title * 6. How confident do you feel clinicians at your institution are in managing patients with infections caused by: Not at all Confident 2 3 4 Very Confident MRSA MRSA Not at all Confident MRSA 2 MRSA 3 MRSA 4 MRSA Very Confident ESBL-producing bacteria ESBL-producing bacteria Not at all Confident ESBL-producing bacteria 2 ESBL-producing bacteria 3 ESBL-producing bacteria 4 ESBL-producing bacteria Very Confident CRE CRE Not at all Confident CRE 2 CRE 3 CRE 4 CRE Very Confident P. aeruginosa P. aeruginosa Not at all Confident P. aeruginosa 2 P. aeruginosa 3 P. aeruginosa 4 P. aeruginosa Very Confident A. baumannii A. baumannii Not at all Confident A. baumannii 2 A. baumannii 3 A. baumannii 4 A. baumannii Very Confident Question Title * 7. For each statement, please answer related to institutional practices during the past 12 months. INCREASED DECREASED NO CHANGE Use of prolonged infusions of beta-lactams Use of prolonged infusions of beta-lactams INCREASED Use of prolonged infusions of beta-lactams DECREASED Use of prolonged infusions of beta-lactams NO CHANGE Frequency of de-escalation of therapy Frequency of de-escalation of therapy INCREASED Frequency of de-escalation of therapy DECREASED Frequency of de-escalation of therapy NO CHANGE Interprofessional communication Interprofessional communication INCREASED Interprofessional communication DECREASED Interprofessional communication NO CHANGE Compliance with infection control measures Compliance with infection control measures INCREASED Compliance with infection control measures DECREASED Compliance with infection control measures NO CHANGE Use of bundled approaches to care Use of bundled approaches to care INCREASED Use of bundled approaches to care DECREASED Use of bundled approaches to care NO CHANGE Question Title * 8. Please rank the following bacterial pathogens as you feel are the greatest threat to hospitalized patients(1=greatest threat, 5=least threat) 1 2 3 4 5 Staphylococcus aureus (including MRSA) 1 2 3 4 5 ESBL-producing Enterobacteriaceae 1 2 3 4 5 Carbapenem-resistant Enterobacteriaceae (CRE) 1 2 3 4 5 Pseudomonas aeruginosa 1 2 3 4 5 Clostridium difficile Question Title * 9. What do you consider to be the greatest challenge when managing C. difficile infections? Timely diagnosis Patient comorbidities Infection recurrence Infection control Effective treatment Other (please specify) Question Title * 10. In your opinion, what are the most significant barriers when treating patients with MDR infections? Done
